Related Experiment Video
Updated: Dec 28, 2025

Isolation of Retinal Arterioles for Ex Vivo Cell Physiology Studies
Published on: July 14, 2018
PEG-LEG ARTERIOLES: AN ADAPTATION TO CHRONIC RETINAL HYPOPERFUSION
1Department of Ophthalmology, Duke University, Durham, North Carolina.
A new retinal vascular sign, resembling a pirate's peg leg, has been identified in patients with chronic retinal hypoperfusion. This finding is linked to severe carotid and vertebral artery disease.
Area of Science:
- Ophthalmology
- Vascular Biology
- Neurology
Background:
- Chronic retinal hypoperfusion is a serious condition affecting vision.
- Severe bilateral occlusive disease of the carotid and vertebral arteries can lead to reduced blood flow to the brain and eyes.
Observation:
- A case report details a 42-year-old woman with a history of nasopharyngeal carcinoma and bilateral occipital infarctions.
- The patient presented with complete occlusion of common carotid arteries and proximal vertebral arteries.
- Fundus examination revealed a novel pattern of retinal vascular remodeling in both eyes.
Findings:
- Retinal arterioles exhibited a unique remodeling pattern: a narrowed proximal segment followed by abrupt dilation.
- This 'pirate's peg leg' appearance was observed in major retinal arterioles, extending peripherally.
- The vascular changes are attributed to adaptive remodeling in response to chronic hypoperfusion.
Implications:
- This newly identified sign provides a potential diagnostic indicator for chronic retinal hypoperfusion.
- Understanding this vascular remodeling may offer insights into cerebrovascular disease progression.
- Further research can explore the clinical significance and diagnostic utility of this sign in ophthalmology and neurology.
More Related Videos
10:46Retinal Cryo-sections, Whole-Mounts, and Hypotonic Isolated Vasculature Preparations for Immunohistochemical Visualization of Microvascular Pericytes
Published on: October 7, 2018
12:28Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022